China 16859-59-9 Factory

Every single member from our large efficiency profits team values customers' requirements and organization communication for 16859-59-9,CAS NO 16859-59-9,Olaparib intermediate,Olaparib advance intermediate,3-hydroxyisobenzofuran-1(3H)-one, In addition, we would properly guideline the shoppers about the application techniques to adopt our products and solutions as well as the way to select appropriate materials.
16859-59-9, With the support of our highly experienced professionals, we manufacture and supply best quality items. These are quality tested at various occasions to ensure only flawless range is delivered to customers, we also customize the array as per the require of customers to meet the requirement of customers.

Hot Products

  • 1,2,3-Triacetyl-5-deoxy-D-ribose

    1,2,3-Triacetyl-5-deoxy-D-ribose

    Product Name:1,2,3-Triacetyl-5-deoxy-D-ribose
    Molecular Formula:C11H16O7
    Molecular Weight:260.24
    CAS Registry Number:62211-93-2
  • 7,10-di-Troc-Docetaxel

    7,10-di-Troc-Docetaxel

    Product Name:7,10-di-Troc-Docetaxel
    Molecular Formula:C49H55Cl6NO18
    Molecular Weight:1158.67
    CAS Registry Number:114915-14-9
  • Nitrofurantoin

    Nitrofurantoin

    Product Name:Nitrofurantoin
    Molecular Formula:C8H6N4O5
    Molecular Weight;238.16
    CAS Registry Number;67-20-9
  • HBTU

    HBTU

    Product Name:HBTU
    Molecular Formula:C11H16F6N5OP
    Molecular Weight:379.25
    CAS Registry Number:94790-37-1
  • Thymosin α1

    Thymosin α1

    Product Name:Thymosin α1
    Molecular Formula:C129H215N33O55
    Molecular Weight;3108.32
    CAS Registry Number;62304-98-7/69440-99-9
  • Tofacitinib Citrate

    Tofacitinib Citrate

    Name:Tofacitinib Citrate
    Molecular Formula:C16H20N6O.C6H8O7
    Molecular Weight:504.50
    CAS NO:540737-29-9
    Usage:Tofacitinib Citrate

Send Inquiry

X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept